Literature DB >> 12066951

Influence of omental biopsy on adjuvant treatment field in clinical Stage I endometrial carcinoma.

Jose J Nieto1, Robert Gornall, Ellen Toms, Suzanne Clarkson, Patrick Hogston, Robert P Woolas.   

Abstract

In this study to assess the role of omental biopsy in the diagnosis of extrapelvic disease, data from 100 consecutive women with clinical Stage I endometrial cancer undergoing primary surgical treatment in our institution were analysed: 80 women had an omental biopsy, 20 did not, and six had adenocarcinoma in the omentum. No obvious morbidity attributable to this rapid and easily performed surgical procedure was recorded. We conclude that visual inspection and palpation of the omentum at the time of abdominal surgery for endometrial carcinoma is worthwhile and advisable. In addition, adopting a protocol of histological assessment upstaged a further two cases of this series. These data suggest that this technique might influence the prescription of adjuvant pelvic radiation in approximately one in 10 women currently considered for such therapy, as disease can be easily documented as having extended beyond the conventional radiotherapy field.

Entities:  

Mesh:

Year:  2002        PMID: 12066951     DOI: 10.1111/j.1471-0528.2002.01272.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  3 in total

1.  What is the importance of omental metastasis in patients with endometrial cancer?

Authors:  Taner Turan; Işın Ureyen; Alper Karalök; Tolga Taşçı; Hilal Ilgın; Levent Keskin; M Faruk Kose; Gökhan Tulunay
Journal:  J Turk Ger Gynecol Assoc       Date:  2014-08-08

2.  The role of omentectomy during the surgical staging in patients with clinical stage I endometrioid adenocarcinoma.

Authors:  Jale Metindir; Gülay Bilir Dilek
Journal:  J Cancer Res Clin Oncol       Date:  2008-04-02       Impact factor: 4.553

3.  Incidence of omental metastasis in uterine serous carcinoma: study protocol for a systematic review and meta-analysis.

Authors:  Cui Hu; Lin-Lin Zhang; Yu Cheng; Fei-Xue Xue; Ya Jia; Qin Zhao-Juan; Du Yi; Zhang Qian-Wen; He Yue-Dong; Zheng Ai; Yu Xu
Journal:  BMJ Open       Date:  2021-01-17       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.